SUN BIOPHARMA RESEARCH, INC.

Profile

Company Names

SUN BIOPHARMA RESEARCH, INC.
SUN BIOPHARMA, INC.

Addresses

712 VISTA BLVD. #305, WACONIA, MN 55387

105 CYPRESS LAGOON COURT, PONTE VEDRA BEACH, FL 32082

Phone Numbers

952-479-1196
(954) 980-5285

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$7,148,898.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2015-09-04 
$1,175,000.00 
$1,175,000.00 
$0.00 
Equity 
3
2014-01-24 
$3,100,000.00 
$6,000,000.00 
$2,900,000.00 
Debt 
2
2013-05-08 
$2,325,000.00 
$2,325,000.00 
$0.00 
Debt 
1
2012-02-25 
$548,898.00 
$2,000,000.00 
$1,451,102.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
T. 
CULLEN 
EXECUTIVE OFFICER, DIRECTOR
SUN BIOPHARMA, INC.   |  SUN BIOPHARMA RESEARCH, INC.   |  SUN BIOPHARMA, INC.   |  PANBELA THERAPEUTICS, INC.
SUZANNE 
 
GAGNON 
EXECUTIVE OFFICER, DIRECTOR
SUN BIOPHARMA RESEARCH, INC.   |  SUN BIOPHARMA, INC.
RYAN 
R. 
GILBERTSON 
EXECUTIVE OFFICER
SUN BIOPHARMA, INC.
JEFFREY 
R. 
HARDER 
DIRECTOR
SUN BIOPHARMA, INC.   |  EF RESOURCES, INC.
PAUL 
M. 
HERRON 
EXECUTIVE OFFICER, DIRECTOR
SUN BIOPHARMA, INC.
CHRISTOPHER 
R. 
JOHNSON 
EXECUTIVE OFFICER
SUN BIOPHARMA, INC.
RANDALL 
L. 
JOHNSON 
EXECUTIVE OFFICER
SUN BIOPHARMA, INC.
DAVID 
B. 
KAYSEN 
EXECUTIVE OFFICER, DIRECTOR
SUN BIOPHARMA RESEARCH, INC.   |  SUN BIOPHARMA, INC.   |  ATRILITY MEDICAL, INC.
CLIFFORD 
F. 
MCCURDY, III 
EXECUTIVE OFFICER, DIRECTOR
SUN BIOPHARMA, INC.
THOMAS 
X. 
NEENAN 
DIRECTOR, EXECUTIVE OFFICER
SUN BIOPHARMA, INC.   |  SUN BIOPHARMA RESEARCH, INC.   |  ABFERO PHARMACEUTICALS, INC.   |  NANITE INC.
DOUGLAS 
M. 
POLINSKY 
EXECUTIVE OFFICER, DIRECTOR
MILL CITY VENTURES III, LTD   |  SUN BIOPHARMA, INC.
DANIEL 
E. 
RYWECK 
EXECUTIVE OFFICER
SUN BIOPHARMA RESEARCH, INC.
PAUL 
W. 
SCHAFFER 
DIRECTOR
SUN BIOPHARMA, INC.   |  SUN BIOPHARMA RESEARCH, INC.   |  SUN BIOPHARMA, INC.
D. 
ROBERT 
SCHEMEL 
DIRECTOR
SUN BIOPHARMA, INC.   |  SUN BIOPHARMA, INC.
DONALD 
R. 
SCHEMEL 
DIRECTOR
SUN BIOPHARMA RESEARCH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-04 
2014-02-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-01-24 
2013-06-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-05-08 
2013-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-05-08 
2012-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#